Skip to main content
    E

    Estrella Immunopharma Inc. (ESLA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.33
    -0.05 (-12.74%)

    Market Cap: $16.53M

    Last updated: Nov 17, 2026 at 4:28 PM ET

    Estrella Immunopharma Inc. (ESLA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Estrella Immunopharma (ESLA) has a market cap of $16.53M and an enterprise value of $16.44M. Its share count is up 17.50% from a year earlier.

    Total Valuation

    Enterprise value is 0.56% below the market cap, as cash exceeds debt.

    Market Cap$16.53M
    Enterprise Value$16.44M
    Latest price (Nov 17, 2026)$0.33

    Key Dates

    The next earnings report is expected on Mar 16, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 16, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.38% in the quarter ended Sep 30, 2026 and grew 9.72% a year over 2 years.

    Shares Outstanding43.59M
    Shares Change (YoY)+17.50%
    Shares Change (QoQ)+1.38%
    Share Count Growth (2Y CAGR)+9.72%

    Price Statistics

    The stock is down 85.39% over 52 weeks and trades 37.74% below its 50-day average.

    Beta (1Y)1.56
    52-Week Change-85.39%
    1-Month Change-12.71%
    3-Month Change-54.99%
    6-Month Change-70.91%
    5-Year Change-93.56%
    Total Return (1Y)-85.39%
    Total Return (3Y CAGR)-35.74%
    Total Return (5Y CAGR)-49.35%
    Max Drawdown (1Y)-85.19%
    Max Drawdown (3Y)-89.70%
    Sharpe Ratio (1Y)-1.14
    Correlation with SPY (1Y)0.14
    50-Day Average$0.53
    200-Day Average$0.96
    52-Week Range$0.24 to $2.27
    RSI (14 Days)41.0
    Average Volume (20 Days)1.89M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.11x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio0.11x
    Quick Ratio0.11x
    Debt / Equity0.00x

    Scores

    ESLA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Balance Sheet

    Cash and Equivalents$92.46K
    Total Debt$0
    Net Cash$92.46K
    Net Cash Per Share$0.00

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Dividends and Yields

    ESLA does not pay a dividend. Its free cash flow yield is -61.39%.

    FCF Yield-61.39%
    Shareholder Yield0.00%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ESLA

    What is ESLA's market cap?

    Estrella Immunopharma has a market cap of $16.53M. Its enterprise value, which adds debt and subtracts cash, is $16.44M.

    How many shares of ESLA are outstanding?

    Estrella Immunopharma has 43.59M shares outstanding. The count is up 17.50% from a year earlier.

    Does ESLA pay a dividend?

    No. Estrella Immunopharma does not pay a dividend.

    How much debt does ESLA have?

    Estrella Immunopharma has $0 of total debt and $92.46K of cash and equivalents, a net cash position of $92.46K.